ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST

(NasdaqGM:RXST), NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the “Class Period”, of the important September 22, 2025 lead plaintiff deadline. SO WHAT: If you […]

ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST

ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RXST GlobeNewswire August 22, 2025 NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024

Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors

(NASDAQ:RCEL), NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP is investigating potential claims against AVITA Medical, Inc. (“AVITA” or the “Company”) (NASDAQ: RCEL). The investigation concerns whether AVITA and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [LEARN MORE

Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors

Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors GlobeNewswire August 22, 2025 NEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) — The law firm of Kirby McInerney LLP is investigating potential claims against AVITA Medical, Inc. (“AVITA” or the “Company”) (NASDAQ: RCEL). The investigation concerns whether AVITA and/or certain of its

Burned by Alto Neuroscience, Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back

NEW YORK, NY / ACCESS Newswire / August 22, 2025 / – SueWallSt: Class Action Filed Against Alto Neuroscience, Inc. – Contact Levi & Korsinsky This lawsuit is on behalf of a class consisting of all persons and entities that purchased or otherwise acquired: (a) Alto common stock pursuant and/or traceable to the Offering Documents

Mississippi Infant Mortality Emergency Underscores US Health Crisis

On August 21, 2025, the Mississippi State Department of Health declared a public health emergency after reporting an alarming rise in infant mortality, on top of already leading the nation in infant death rates. March of Dimes, the nation's leading nonprofit fighting for the health of moms and babies, issued the following response from President

PUBM Investors with Losses in Excess of $100K Have Opportunity to Lead PubMatic, Inc. Securities Lawsuit

https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg Why:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. – HIMS

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased the Company's securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”).

ANRO Investors Have Opportunity to Lead Alto Neuroscience, Inc. Securities Fraud Lawsuit

Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto's initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024, both dates inclusive (the “Class Period”),

Scroll to Top